Acadian Asset Management LLC Arca Biopharma, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.77 - $2.49 $102,344 - $143,976	-57,822 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.15 - $2.97 $124,317 - $171,731	57,822 New	57,822 $123,000
Q3 2020 Nov 09, 2020	SELL	$4.07 - $7.99 $85,095 - $167,054	-20,908 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$2.69 - $19.21 $20,215 - $144,363	-7,515 Reduced 26.44%	20,908 $138,000
Q1 2020 May 11, 2020	BUY	$2.32 - $6.42 $25,728 - $71,197	11,090 Added 63.98%	28,423 $80,000
Q2 2019 Aug 08, 2019	BUY	$5.15 - $15.1 $89,264 - $261,728	17,333 New	17,333 $128,000

13M

41.6K

5.6K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.